Lundbeck
HLUN-B.CO
#2586
Rank
โ‚น464.71 B
Marketcap
โ‚น487.48
Share price
-1.88%
Change (1 day)
24.64%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): โ‚น29.01

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is โ‚น30.02. In 2022 the company made an earnings per share (EPS) of โ‚น22.83 a decrease over its 2021 EPS that were of โ‚น51.28.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น29.0127.06%
2022โ‚น22.83-55.47%
2021โ‚น51.28-51.83%
2020โ‚น106.44-28.01%
2019โ‚น147.86-44.08%
2018โ‚น264.4151.94%
2017โ‚น174.02126.64%
2016โ‚น76.78-120.84%
2015-โ‚น368.455622.18%
2014-โ‚น6.44-110.03%
2013โ‚น64.17-28.08%
2012โ‚น89.23-52.1%
2011โ‚น186.28-1.31%
2010โ‚น188.7615.61%
2009โ‚น163.27